ArticleFrontiers in immunology2026

Harnessing SARS-CoV-2 immunity to promote antitumor responses through intratumoral vaccination and adoptive transfer.

Manar Darwish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.